SCHEMBL492549

SCHEMBL492549

CCOC(=O)c1nsc2cc(N3CCC(N(C)C(=O)OC(C)(C)C)C3)ccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 2/20 0.38
AAK1 Q2M2I8 1/20 0.38
GPR119 Q8TDV5 2/20 0.36
KDM4D Q6B0I6 1/20 0.36
PIK3CD O00329 1/20 0.36
NR1H2 P55055 1/20 0.36
NR1H3 Q13133 1/20 0.36
LGMN Q99538 1/20 0.36
SPR P35270 3/20 0.35
JAK2 O60674 2/20 0.35
JAK1 P23458 1/20 0.35
JAK3 P52333 1/20 0.35
DDR1 Q08345 1/20 0.35
RET P07949 1/20 0.34
KIF18A Q8NI77 1/20 0.34
HSD11B1 P28845 1/20 0.34
HTR1A P08908 1/20 0.34
DRD2 P14416 1/20 0.34
HTR2A P28223 1/20 0.34
DRD3 P35462 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL492284 0.89 PDE10A (0.42) PDE10AAAK1KDM4DPIK3CDSPR
SCHEMBL492226 0.79 IDH1 (0.39) LGMNHTR1ADRD2HTR2ADRD3
SCHEMBL492141 0.76 MAPT (0.43) GPR119
SCHEMBL492049 0.74 MCHR1 (0.43)
SCHEMBL492199 0.74 MCHR1 (0.43)
SCHEMBL492277 0.74 ADRB1 (0.40)
SCHEMBL492393 0.72 PARP1 (0.42) GPR119NR1H2NR1H3SPRRET
SCHEMBL22434716 0.72 PDE10A (0.47) PDE10AAAK1GPR119KDM4DSPR
SCHEMBL22434605 0.72 PDE10A (0.47) PDE10AAAK1GPR119KDM4DSPR
SCHEMBL492632 0.71 NOTUM (0.37) JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106066-B2 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof MEMORY PHARMACEUTICALS CORPORATION (US) 2012-01-31 US disclosed
US-20070078147-A1 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof MEMORY PHARMACEUTICALS CORPORATION 2007-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078147-A1 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof CHRNA7, CHRNA5, CHRNA2 PDE10A 1911/4885AAK1 2051/4885GPR119 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.